Maryland State Retirement & Pension System’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.96M | Hold |
6,021
| – | – | 0.04% | 332 |
|
2025
Q1 | $1.63M | Sell |
6,021
-969
| -14% | -$262K | 0.04% | 347 |
|
2024
Q4 | $1.64M | Sell |
6,990
-203
| -3% | -$47.8K | 0.04% | 399 |
|
2024
Q3 | $1.98M | Sell |
7,193
-2,643
| -27% | -$727K | 0.04% | 359 |
|
2024
Q2 | $2.39M | Hold |
9,836
| – | – | 0.04% | 342 |
|
2024
Q1 | $1.44M | Buy |
9,836
+385
| +4% | +$56.4K | 0.03% | 484 |
|
2023
Q4 | $1.81M | Hold |
9,451
| – | – | 0.04% | 395 |
|
2023
Q3 | $1.67M | Hold |
9,451
| – | – | 0.04% | 392 |
|
2023
Q2 | $1.8M | Sell |
9,451
-214
| -2% | -$40.6K | 0.04% | 399 |
|
2023
Q1 | $1.94M | Hold |
9,665
| – | – | 0.04% | 352 |
|
2022
Q4 | $2.3M | Buy |
9,665
+305
| +3% | +$72.5K | 0.07% | 270 |
|
2022
Q3 | $1.87M | Buy |
9,360
+261
| +3% | +$52.2K | 0.16% | 110 |
|
2022
Q2 | $1.33M | Hold |
9,099
| – | – | 0.04% | 392 |
|
2022
Q1 | $1.49M | Hold |
9,099
| – | – | 0.04% | 416 |
|
2021
Q4 | $1.54M | Buy |
9,099
+272
| +3% | +$46.1K | 0.04% | 427 |
|
2021
Q3 | $1.62M | Hold |
8,827
| – | – | 0.05% | 380 |
|
2021
Q2 | $1.54M | Hold |
8,827
| – | – | 0.05% | 364 |
|
2021
Q1 | $1.25M | Buy |
8,827
+6,965
| +374% | +$983K | 0.04% | 412 |
|
2020
Q4 | $288K | Buy |
+1,862
| New | +$288K | 0.05% | 350 |
|